Pubblicazioni

CT imaging phenotypes linked to CA125 and HE4 biomarkers are highly predictive in discriminating between hereditary and sporadic ovarian cancer patients

2022 - TUMOR BIOLOGY

Manganaro, Lucia; Celli, Veronica; Viggiani, Valentina; Berardelli, Elena; Granato, Teresa; Tartaglione, Sara; Farina, Antonella; Catalano, Carlo; Angeloni, Antonio; Anastasi, Emanuela

Beyond circulating microRNA biomarkers: urinary microRNAs in ovarian and breast cancer

2017 - TUMOR BIOLOGY

Gasparri, Maria Luisa; Casorelli, Assunta; Bardhi, Erlisa; Besharat, Aris Raad; Savone, Delia; Ruscito, Ilary; Farooqi, Ammad Ahmad; Papadia, Andrea; Mueller, Michael David; Ferretti, Elisabetta; Panici, Pierluigi Benedetti

Cediranib in ovarian cancer. state of the art and future perspectives

2016 - TUMOR BIOLOGY

Ruscito, Ilary; Gasparri, Marialuisa; Marchetti, Claudia; DE MEDICI, Caterina; Bracchi, Carlotta; Palaia, Innocenza; Imboden, S; Mueller, Md; Papadia, A; Muzii, Ludovico; BENEDETTI PANICI, Pierluigi

Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium

2016 - TUMOR BIOLOGY

Dimitrova, D; Ruscito, I; Olek, S; Richter, R; Hellwag, A; TÃ¼rbachova, I; Woopen, H; Baron, U; Braicu, Ei; Sehouli, J.